SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

All news > Video

Consolidation prevalent in industry, says third largest CMO

Consolidation prevalent in industry, says third largest CMO

Brad Carlson

VP Marketing 7 Sales - Aenova

Aenova says the acquisition of Haupt Pharma and Patheon’s merger with DSM are evidence of consolidation in the CMO industry, as it looks to further increase its global footprint.

Published: 26-Mar-2014

Catalent commits to ADCs by upping its stake in Redwood

Catalent commits to ADCs by upping its stake in Redwood

Aileen Ruff

Global Strategic Marketing Director, Biologics and Sterile Technologies at Catalent - Catalent

Catalent has increased its stake in Redwood Biosciences telling us it is committed to the development of antibody-drug conjugates (ADCs) and the SMARTag technology platform.

Published: 25-Mar-2014

Patheon and DSM crossover limited, more growth targeted says DPx

Patheon and DSM crossover limited, more growth targeted says DPx

Joe Principe

Patheon and DSM’s Pharma Products merger is “highly complementary” with crossover limited to North American oral solid manufacturing growth, says DPx as it targets further growth opportunities.

Published: 20-Mar-2014

Kemwell Talks Expansion and Approvals in India and the US

Kemwell Talks Expansion and Approvals in India and the US

Christian Ahlmark

Director of Corporate Development - Kemwell Biopharma

At this year’s Interphex, Kemwell Biopharma spoke to Outsourcing-Pharma.com about recent expansions in both India and the US.

Published: 27-May-2013

TFS Sees Increase in Modularization, Shorter Construction Timelines

Jose Garcia

Biopharma companies are looking for more pre-fabrication of their facilities and to be able to expedite construction and meet tighter timelines, an expert told Outsourcing-Pharma.com.

Published: 21-May-2013

AMRI Exec Discusses 'New Bar' in FDA Enforcement

Following the completion of remediation efforts to deal with an FDA warning letter, Chris Phillips, AMRI's senior director of its Burlington, Massachusetts site, discusses what he considers to be a "new bar" in enforcement activity from the agency since 2009.

Published: 02-May-2013

Happy holidays from William Reed Business Media!

Happy holidays from William Reed Business Media!

The working year is almost done, time to pause from ‘the business’ and embrace the festive season…go on, give it a big hug. Happy holidays!

Published: 19-Dec-2012

Aesica says academic partnerships are key for CMOs

Aesica says academic partnerships are key for CMOs

Alan Raymond

Sales & Marketing Director - Aesica Pharmaceuticals

UK CMO Aesica Pharmaceutical says that working with academia to access cutting edge technologies is critical for contractors that want to meet the demands of the modern drug industry.

Published: 06-Dec-2012

Wockhardt targets CMO space for diversification

Wockhardt targets CMO space for diversification

Tom Salus

Associate Vice President, Business Development - Contract Services - Wockhardt

Wockhardt sees the ‘fractured CMO space’ as providing opportunities for growth, diversification and greater capacity utilisation.

Published: 14-Jun-2012

Kemwell and Boehringer set to finish biologics plant in India

Kemwell and Boehringer set to finish biologics plant in India

Christian Ahlmark

Director of corporate development - Kemwell

Kemwell is set to complete a new biologics manufacturing facility in Bangalore, India, following its long-term partnership with Boehringer Ingelheim.

Published: 29-May-2012

Patheon launches CMC consultancy in face of restructuring plans

Patheon launches CMC consultancy in face of restructuring plans

Geoff Glass

Executive VP of global sales and marketing - Patheon

Patheon has launched a new consulting service designed to give emerging biotechs and pharmas a boost in their drug development efforts.

Published: 15-May-2012

Parexel discusses transdermal drug delivery techs

Parexel discusses transdermal drug delivery techs

Ravi Harapanhalli

Principal Consultant and Practice Lead for Late Stage Product Development Parexel Consulting - Parexel

Electroporation is the wave of the future for transdermal drug delivery, according to Parexel’s Ravi Harapanhalli.

Published: 22-Dec-2011

Quotient says screening of prototype formulations is crucial to drug delivery

Quotient says screening of prototype formulations is crucial to drug delivery

Peter Schole

VP, pharmaceutical sciences - Quotient Clinical

Quotient has stressed the importance of screening prototype formulations early in the development process to ensure efficient drug delivery in later phases.

Published: 13-Dec-2011

Covance adding mass spec for biosimilars

Covance adding mass spec for biosimilars

Ray Kaiser

Chief Scientific Officer, Biotechnology - Covance

Covance is adding mass spectrometry and other capabilities to meet growing demand for biosimilar comparability services.

Published: 23-Nov-2011

Patheon mulls drug delivery tech deals to accelerate development services growth

Patheon mulls drug delivery tech deals to accelerate development services growth

Mark Kontny

President, Global Pharmaceutical Development Services - Patheon

Patheon is considering buying unique drug delivery technologies to expand its development service capabilities.

Published: 14-Nov-2011

Catalent eyes acquisitions in emerging market and drug delivery expansion

Catalent eyes acquisitions in emerging market and drug delivery expansion

Scott Houlton

President, Development and Clinical Services - Catalent

Catalent is considering acquisitions as it adds scale, drug delivery technologies and capacity in emerging markets.

Published: 07-Nov-2011

Icon sets its sights on genomics development

Icon sets its sights on genomics development

Brian O’Dwyer

senior VP for global bioanalytical services - Icon

Icon will this year focus its R&D efforts on gaining new grounds in genomics, said Brian O’Dwyer.Icon

Published: 31-Oct-2011

Norwich amps up its pilot scale production capabilities at NY plant

Norwich amps up its pilot scale production capabilities at NY plant

Terry Novak

President - Norwich Pharmaceuticals

Norwich Pharmaceuticals has expanded its pilot scale production capabilities at its CDMO plant in New York, US.

Published: 27-Oct-2011

Novozymes reveals the key to its supply chain management strategy

Novozymes reveals the key to its supply chain management strategy

Luke Dimasi

marketing manager - Novozymes

Novozymes has achieved a successful supply chain and risk mitigation strategy through implementing its own policy with chemicals company SAFC, says Luke Dimasi.

Published: 26-Sep-2011

New growth strategy and supply chain management system in place for SAFC, says president Gilles Cottier

New growth strategy and supply chain management system in place for SAFC, says president Gilles Cottier

Gilles Cottier

President - SAFC

SAFC announced its new aggressive growth strategy, including plans to expand in the developing markets, at its conference in Irvine, Glasgow last week.

Published: 19-Sep-2011

Rapid recruitment in emerging regions can overload sites; FDA

Rapid recruitment in emerging regions can overload sites; FDA

Cynthia Kleppinger

Medical Officer, Division of Scientific Investigations - CDER, FDA

The US FDA has warned that rapid patient enrolment in emerging markets can overload sites that lack the staff to oversee data as it is generated.

Published: 18-Aug-2011

Apps turn iPads & iPods into consent & compliance tools

Apps turn iPads & iPods into consent & compliance tools

Jay Udani

CEO - Medicus Research

Systemedicus has developed informed consent and patient compliance apps for iPads and iPods and is looking to license the tools to CROs and sponsors.

Published: 08-Aug-2011

Sponsors and CROs both have key role in quality; FDA

Sponsors and CROs both have key role in quality; FDA

Ann Meeker O’Connell

Acting Associate Director of Risk Science, Intelligence & Prioritization - FDA

The FDA is emphasising the key role both sponsors and CROs play in ensuring high quality clinical trials.

Published: 03-Aug-2011

ACRO, Quintiles, PRA and Theorem talk strategic partnering at DIA 2011

ACRO, Quintiles, PRA and Theorem talk strategic partnering at DIA 2011

The Big Pharma CRO strategic partnering model, its impact on drug development and the contract research sector was a hot topic at DIA 2011.

Published: 02-Aug-2011

OSP meets Pfizer's REMOTE virtual trial partners at DIA 2011

OSP meets Pfizer's REMOTE virtual trial partners at DIA 2011

In June global drug giant Pfizer began what it described as the world’s first ‘virtual trial’ using mobile technology to collect data from patients in their own homes rather than at research sites.

Published: 27-Jul-2011

Key Industry Events

 

Access all events listing

Our events, Events from partners...